The FDA has approved three self-administered tests for the high-risk strains of HPV known to cause most cervical cancers.

In early December, the American Cancer Society updated its guidelines for the first time since 2020. Now, all women nationwide are eligible for at-home cervical cancer screening.

The U.S. Food and Drug Administration has approved the country’s first at-home HPV screening device. The test is designed as an alternative to the Pap smear, a procedure that detects precancerous ...

Cervical cancer usually does not cause symptoms until it is advanced. A new guideline makes it easier to detect when precancerous changes are already developing.

Investigators examined cervical cancer screening guideline adherence among a nationally representative commercially insured cohort in the US to identify factors and modalities associated with ...

A revolutionary development in cervical cancer screening is transforming the way millions of women approach their health care. The FDA’s recent approval of self-collection kits from leading healthcare ...

The American Cancer Society (ACS) has officially updated its cervical cancer screening guidelines, marking one of the most ...

It’s a move that could alter care for millions of women and significantly affect those across the Brazos Valley, especially in rural counties.

Cervical cancer screening adherence is below 10%, with frequent guideline updates causing confusion among patients and clinicians. The COVID-19 pandemic worsened nonadherence and HPV vaccine awareness ...

Global HPV Testing and PAP Test Market OverviewThe global HPV testing and PAP tests market is projected to expand steadily, registering a compound annual growth rate of approximately 12–15% through ...